Bladder Cancer at the time of COVID-19 Outbreak

Esperto, Francesco; Pang, Karl K.H.; Albisinni, Simone; Papalia, Rocco; Scarpa, Roberto

doi:10.1590/s1677-5538.ibju.2020.s107

Cited by 9 publications

(4 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients with T3-4 and/or lymph node involvement, cisplatin-based adjuvant chemotherapy can be applied if neoadjuvant chemotherapy (NAC) is not given. Radiotherapy for hemostasis should be considered for MIBC with active bleeding who cannot undergo radical cystectomy (17,18).…”

Section: Discussionmentioning

confidence: 99%

Comparative assessment of patients' admission to urology departments during and before the COVID-19 pandemic: a retrospective cohort study

Keleş

Karakeçi

Ozan

et al. 2023

Journal of Health Sciences and Medicine

View full text Add to dashboard Cite

Aim: To determine the diseases that presented to the urology department during the COVID-19 pandemic and for hospital-based comparison with the diseases that presented in the same period of the previous year. Material and Method: In this retrospective follow-up study, patients who were admitted to the tertiary university hospital and secondary state hospital urology departments between April-July 2019 and April-July 2020 were included in the study. We searched the health administrative data using the International Classification of Diseases-10 codes. The number and variety of patients who were admitted to the urology departments in the same months of 2019 and 2020 were compared. Results: In both hospitals, the total number of admissions decreased during the pandemic in 2020 compared to the pre-pandemic year. Also, elective admissions decreased in 2020 compared to the pre-pandemic year (p

show abstract

Section: Discussionmentioning

confidence: 99%

Comparative assessment of patients' admission to urology departments during and before the COVID-19 pandemic: a retrospective cohort study

Keleş

Karakeçi

Ozan

et al. 2023

Journal of Health Sciences and Medicine

View full text Add to dashboard Cite

show abstract

“…In Brazil, many health care institutions had their non-urgent procedures and elective surgeries suspended for months to concentrate economic and human resources to respond to the COVID-19 outbreak waves (10). With that, guidelines and suggestions have been provided to categorize urological diseases into risk groups and recommendations for follow-up during the COVID-19 outbreak in the management of numerous neoplasms (11,12).…”

Section: Commentmentioning

confidence: 99%

Recommendations for prostate cancer diagnosis and treatment during COVID-19 outbreak were not followed in Brazil

et al. 2022

View full text Add to dashboard Cite

“… 35 High priority cases should be treated within <6 weeks and include: TURBT for suspicious invasive tumor identified on imaging; consider alternatives such as radiotherapy ± chemotherapy to palliative radical cystectomy; neoadjuvant chemotherapy (NAC) for individualize risk in high burden T3–4 N0M0 patients while they are on the waiting list; offer adjuvant cisplatin-based combination chemotherapy to patients with T3–4 and/or pN+ disease if no NAC was given. 36 High-risk nonmuscle-invasive bladder cancer (NMIBC) progression and worse prognosis are also characterized by a higher incidence in patients with risk factors similar to COVID-19. Immune system response and inflammation have been found as a common hallmark of both diseases.…”

Section: Uro-oncological Surgeries During Covid-19 Pandemicmentioning

confidence: 99%

The Impact of COVID-19 Disease on Urology Practice

et al. 2021

View full text Add to dashboard Cite

The diagnosis and timely treatment of cancer patients should not be compromised during an infectious disease pandemic. The pandemic of coronavirus disease 2019 (COVID-19) has serious implications on urology practice and raises particular questions for urologists about the management of different conditions. It was recommended to cancel most of the elective urological surgeries. Urological cancers surgeries that should be prioritized are radical cystectomy for selective tumors, orchiectomy for suspected testicular tumors, nephrectomy for c T3 + , nephroureterectomy for high-grade disease, and radical adrenalectomy for tumors >6 cm or adrenal carcinoma. Most prostatectomies can be delayed without compromising the survival rate of patients. Urological emergencies should be treated adequately even during this pandemic. There is a potential risk of coronavirus diffusion during minimally invasive procedures performed. It is crucial to use specific precautions when urologists performed those type of surgeries. It was also recommended to suspend the kidney transplantation program during the COVID-19 pandemic except for specific cases. In this review, we discussed the triage of urological surgeries, the risk of minimally invasive urological procedure, the kidney transplantation challenges, the systemic therapies, intravesical instillation of Bacillus Calmette-Guérin (BCG), endourology, teleconferencing, and telemedicine application in urology during the COVID-19 pandemic.

show abstract

Bladder Cancer at the time of COVID-19 Outbreak

Cited by 9 publications

References 37 publications

Comparative assessment of patients' admission to urology departments during and before the COVID-19 pandemic: a retrospective cohort study

Comparative assessment of patients' admission to urology departments during and before the COVID-19 pandemic: a retrospective cohort study

Recommendations for prostate cancer diagnosis and treatment during COVID-19 outbreak were not followed in Brazil

The Impact of COVID-19 Disease on Urology Practice

Contact Info

Product

Resources

About